Banks - Regional
Compare Stocks
5 / 10Stock Comparison
TRMK vs HOMB vs SFNC vs IBCP vs FFIN
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
TRMK vs HOMB vs SFNC vs IBCP vs FFIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $2.64B | $5.26B | $3.10B | $690M | $4.58B |
| Revenue (TTM) | $1.12B | $1.45B | $627M | $315M | $739M |
| Net Income (TTM) | $224M | $458M | $-398M | $69M | $243M |
| Gross Margin | 71.0% | 65.6% | 5.8% | 69.6% | 70.8% |
| Operating Margin | 25.5% | 36.0% | -84.2% | 25.8% | 36.8% |
| Forward P/E | 11.5x | 10.8x | 10.4x | 9.4x | 15.8x |
| Total Debt | $1.12B | $1.20B | $641M | $117M | $197M |
| Cash & Equiv. | $668M | $910M | $380M | $52M | $763M |
TRMK vs HOMB vs SFNC vs IBCP vs FFIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Trustmark Corporati… (TRMK) | 100 | 188.1 | +88.1% |
| Home Bancshares, In… (HOMB) | 100 | 184.5 | +84.5% |
| Simmons First Natio… (SFNC) | 100 | 124.9 | +24.9% |
| Independent Bank Co… (IBCP) | 100 | 242.5 | +142.5% |
| First Financial Ban… (FFIN) | 100 | 105.2 | +5.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TRMK vs HOMB vs SFNC vs IBCP vs FFIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TRMK carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 1.42 vs HOMB's 3.53
- 34.8% NII/revenue growth vs SFNC's -56.7%
- Lower P/E (11.5x vs 15.8x), PEG 1.42 vs 3.04
- +31.7% vs FFIN's -4.2%
HOMB is the #2 pick in this set and the best alternative if income & stability and bank quality is your priority.
- Dividend streak 21 yrs, beta 0.82, yield 2.8%
- NIM 3.8% vs SFNC's 2.9%
- Efficiency ratio 0.3% vs SFNC's 0.9% (lower = leaner)
- Beta 0.82 vs SFNC's 1.02
SFNC ranks third and is worth considering specifically for dividends.
- 4.0% yield, 6-year raise streak, vs HOMB's 2.8%
IBCP is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 181.9% 10Y total return vs TRMK's 127.7%
- Lower volatility, beta 0.83, Low D/E 23.2%, current ratio 370.62x
- Beta 0.83, yield 3.1%, current ratio 370.62x
FFIN is the clearest fit if your priority is growth exposure.
- Rev growth 18.8%, EPS growth 12.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 34.8% NII/revenue growth vs SFNC's -56.7% | |
| Value | Lower P/E (11.5x vs 15.8x), PEG 1.42 vs 3.04 | |
| Quality / Margins | Efficiency ratio 0.3% vs SFNC's 0.9% (lower = leaner) | |
| Stability / Safety | Beta 0.82 vs SFNC's 1.02 | |
| Dividends | 4.0% yield, 6-year raise streak, vs HOMB's 2.8% | |
| Momentum (1Y) | +31.7% vs FFIN's -4.2% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs SFNC's 0.9% |
TRMK vs HOMB vs SFNC vs IBCP vs FFIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
TRMK vs HOMB vs SFNC vs IBCP vs FFIN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FFIN leads in 1 of 6 categories
IBCP leads 1 • TRMK leads 0 • HOMB leads 0 • SFNC leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — SFNC and FFIN each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
HOMB is the larger business by revenue, generating $1.5B annually — 4.6x IBCP's $315M. FFIN is the more profitable business, keeping 30.2% of every revenue dollar as net income compared to SFNC's -63.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $1.5B | $627M | $315M | $739M |
| EBITDAEarnings before interest/tax | $323M | $601M | -$497M | $89M | $310M |
| Net IncomeAfter-tax profit | $224M | $458M | -$398M | $69M | $243M |
| Free Cash FlowCash after capex | $230M | $354M | $755M | $70M | $290M |
| Gross MarginGross profit ÷ Revenue | +71.0% | +65.6% | +5.8% | +69.6% | +70.8% |
| Operating MarginEBIT ÷ Revenue | +25.5% | +36.0% | -84.2% | +25.8% | +36.8% |
| Net MarginNet income ÷ Revenue | +20.0% | +27.7% | -63.4% | +21.7% | +30.2% |
| FCF MarginFCF ÷ Revenue | +20.7% | +29.1% | +71.7% | +22.2% | +39.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +5.4% | +26.0% | +42.1% | +2.3% | -7.7% |
Valuation Metrics
Evenly matched — SFNC and IBCP each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 10.3x trailing earnings, IBCP trades at a 50% valuation discount to FFIN's 20.7x P/E. Adjusting for growth (PEG ratio), TRMK offers better value at 1.50x vs HOMB's 4.36x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.6B | $5.3B | $3.1B | $690M | $4.6B |
| Enterprise ValueMkt cap + debt − cash | $3.1B | $5.5B | $3.4B | $755M | $4.0B |
| Trailing P/EPrice ÷ TTM EPS | 12.10x | 13.28x | -7.26x | 10.25x | 20.65x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.46x | 10.75x | 10.38x | 9.44x | 15.83x |
| PEG RatioP/E ÷ EPS growth rate | 1.50x | 4.36x | — | 1.95x | 3.96x |
| EV / EBITDAEnterprise value multiple | 9.47x | 10.06x | — | 9.28x | 14.08x |
| Price / SalesMarket cap ÷ Revenue | 2.35x | 3.62x | 4.95x | 2.19x | 6.20x |
| Price / BookPrice ÷ Book value/share | 1.28x | 1.35x | 0.84x | 1.39x | 2.87x |
| Price / FCFMarket cap ÷ FCF | 11.36x | 12.45x | 6.90x | 9.83x | 15.65x |
Profitability & Efficiency
FFIN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
IBCP delivers a 14.2% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-12 for SFNC. FFIN carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to TRMK's 0.53x. On the Piotroski fundamental quality scale (0–9), IBCP scores 8/9 vs SFNC's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.8% | +10.9% | -11.6% | +14.2% | +13.3% |
| ROA (TTM)Return on assets | +1.2% | +2.0% | -1.6% | +1.3% | +1.6% |
| ROICReturn on invested capital | +7.1% | +7.2% | -9.1% | +10.2% | +11.0% |
| ROCEReturn on capital employed | +3.2% | +9.8% | -4.2% | +2.6% | +16.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 4 | 8 | 6 |
| Debt / EquityFinancial leverage | 0.53x | 0.30x | 0.19x | 0.23x | 0.12x |
| Net DebtTotal debt minus cash | $448M | $292M | $261M | $65M | -$566M |
| Cash & Equiv.Liquid assets | $668M | $910M | $380M | $52M | $763M |
| Total DebtShort + long-term debt | $1.1B | $1.2B | $641M | $117M | $197M |
| Interest CoverageEBIT ÷ Interest expense | 0.75x | 1.44x | -1.01x | 0.91x | 1.48x |
Total Returns (Dividends Reinvested)
IBCP leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IBCP five years ago would be worth $16,340 today (with dividends reinvested), compared to $7,043 for FFIN. Over the past 12 months, TRMK leads with a +31.7% total return vs FFIN's -4.2%. The 3-year compound annual growth rate (CAGR) favors IBCP at 30.8% vs FFIN's 7.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +15.1% | -3.6% | +15.0% | +5.9% | +8.0% |
| 1-Year ReturnPast 12 months | +31.7% | -3.0% | +15.7% | +11.2% | -4.2% |
| 3-Year ReturnCumulative with dividends | +110.9% | +38.4% | +49.4% | +123.9% | +23.6% |
| 5-Year ReturnCumulative with dividends | +48.4% | +6.2% | -14.0% | +63.4% | -29.6% |
| 10-Year ReturnCumulative with dividends | +127.7% | +58.2% | +26.3% | +181.9% | +145.2% |
| CAGR (3Y)Annualised 3-year return | +28.2% | +11.4% | +14.3% | +30.8% | +7.3% |
Risk & Volatility
Evenly matched — TRMK and HOMB each lead in 1 of 2 comparable metrics.
Risk & Volatility
HOMB is the less volatile stock with a 0.82 beta — it tends to amplify market swings less than SFNC's 1.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TRMK currently trades 97.3% from its 52-week high vs FFIN's 83.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.94x | 0.82x | 1.02x | 0.83x | 0.95x |
| 52-Week HighHighest price in past year | $45.99 | $30.83 | $22.18 | $37.39 | $38.74 |
| 52-Week LowLowest price in past year | $33.39 | $25.68 | $17.00 | $29.63 | $28.11 |
| % of 52W HighCurrent price vs 52-week peak | +97.3% | +86.6% | +96.6% | +89.6% | +83.2% |
| RSI (14)Momentum oscillator 0–100 | 51.8 | 43.6 | 56.2 | 43.0 | 52.0 |
| Avg Volume (50D)Average daily shares traded | 396K | 1.5M | 1.2M | 177K | 727K |
Analyst Outlook
Evenly matched — HOMB and SFNC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TRMK as "Hold", HOMB as "Hold", SFNC as "Buy", IBCP as "Hold", FFIN as "Hold". Consensus price targets imply 21.8% upside for FFIN (target: $39) vs 1.7% for TRMK (target: $46). For income investors, SFNC offers the higher dividend yield at 3.99% vs TRMK's 2.16%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $45.50 | $32.00 | $22.67 | $38.00 | $39.25 |
| # AnalystsCovering analysts | 9 | 19 | 9 | 7 | 15 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | +2.8% | +4.0% | +3.1% | +2.2% |
| Dividend StreakConsecutive years of raises | 1 | 21 | 6 | 11 | 11 |
| Dividend / ShareAnnual DPS | $0.97 | $0.75 | $0.85 | $1.03 | $0.72 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.0% | +1.6% | 0.0% | +1.8% | 0.0% |
FFIN leads in 1 of 6 categories (Profitability & Efficiency). IBCP leads in 1 (Total Returns). 4 tied.
TRMK vs HOMB vs SFNC vs IBCP vs FFIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TRMK or HOMB or SFNC or IBCP or FFIN a better buy right now?
For growth investors, Trustmark Corporation (TRMK) is the stronger pick with 34.
8% revenue growth year-over-year, versus -56. 7% for Simmons First National Corporation (SFNC). Independent Bank Corporation (IBCP) offers the better valuation at 10. 3x trailing P/E (9. 4x forward), making it the more compelling value choice. Analysts rate Simmons First National Corporation (SFNC) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TRMK or HOMB or SFNC or IBCP or FFIN?
On trailing P/E, Independent Bank Corporation (IBCP) is the cheapest at 10.
3x versus First Financial Bankshares, Inc. at 20. 7x. On forward P/E, Independent Bank Corporation is actually cheaper at 9. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Trustmark Corporation wins at 1. 42x versus Home Bancshares, Inc. 's 3. 53x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — TRMK or HOMB or SFNC or IBCP or FFIN?
Over the past 5 years, Independent Bank Corporation (IBCP) delivered a total return of +63.
4%, compared to -29. 6% for First Financial Bankshares, Inc. (FFIN). Over 10 years, the gap is even starker: IBCP returned +181. 9% versus SFNC's +26. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TRMK or HOMB or SFNC or IBCP or FFIN?
By beta (market sensitivity over 5 years), Home Bancshares, Inc.
(HOMB) is the lower-risk stock at 0. 82β versus Simmons First National Corporation's 1. 02β — meaning SFNC is approximately 25% more volatile than HOMB relative to the S&P 500. On balance sheet safety, First Financial Bankshares, Inc. (FFIN) carries a lower debt/equity ratio of 12% versus 53% for Trustmark Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — TRMK or HOMB or SFNC or IBCP or FFIN?
By revenue growth (latest reported year), Trustmark Corporation (TRMK) is pulling ahead at 34.
8% versus -56. 7% for Simmons First National Corporation (SFNC). On earnings-per-share growth, the picture is similar: First Financial Bankshares, Inc. grew EPS 12. 2% year-over-year, compared to -343. 8% for Simmons First National Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TRMK or HOMB or SFNC or IBCP or FFIN?
First Financial Bankshares, Inc.
(FFIN) is the more profitable company, earning 30. 2% net margin versus -63. 4% for Simmons First National Corporation — meaning it keeps 30. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FFIN leads at 36. 8% versus -84. 2% for SFNC. At the gross margin level — before operating expenses — TRMK leads at 71. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TRMK or HOMB or SFNC or IBCP or FFIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Trustmark Corporation (TRMK) is the more undervalued stock at a PEG of 1. 42x versus Home Bancshares, Inc. 's 3. 53x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Independent Bank Corporation (IBCP) trades at 9. 4x forward P/E versus 15. 8x for First Financial Bankshares, Inc. — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FFIN: 21. 8% to $39. 25.
08Which pays a better dividend — TRMK or HOMB or SFNC or IBCP or FFIN?
All stocks in this comparison pay dividends.
Simmons First National Corporation (SFNC) offers the highest yield at 4. 0%, versus 2. 2% for Trustmark Corporation (TRMK).
09Is TRMK or HOMB or SFNC or IBCP or FFIN better for a retirement portfolio?
For long-horizon retirement investors, Independent Bank Corporation (IBCP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
83), 3. 1% yield, +181. 9% 10Y return). Both have compounded well over 10 years (IBCP: +181. 9%, SFNC: +26. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TRMK and HOMB and SFNC and IBCP and FFIN?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TRMK is a small-cap high-growth stock; HOMB is a small-cap deep-value stock; SFNC is a small-cap income-oriented stock; IBCP is a small-cap deep-value stock; FFIN is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.